How to optimize prescription of antimicrobial drugs

Acta Clinica Belgica

Volumn 54, Issue 1, 1999, Pages 7-12

  Gyssens, Inge C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DRUG CHOICE; DRUG MISUSE; DRUG SURVEILLANCE PROGRAM; DRUG USE; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW;

EID: 0033048523     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.1999.11754200     Document Type: Review

References (8)

1. Halls G A. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31:985-1000.
2. Van der Meer JWM, Gyssens IC. Considerations in providing antibiotic therapy. The APUA Newsletter 1992; winter: 3-5.
3. Working Party of the British Society for Antimicrobial Chemotherapy. Hospital antibiotic control measures in the UK. J Antimicrob Chemother 1994; 34: 21-42.
4. Kunin CM. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973; 79: 555-560.
5. Mertens R, Verbist L, Gordts B, et al. National study on the utilization of prophylactic antibiotics in surgery, Belgium, 1986. Epidemiol Infect 1989; 103: 311-322.
6. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1996; 279: 365-370.
7. Struelens MI. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ 1998; 317: 652-654.
8. Archibald L, Phillips L, Monnet D, et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215.